Singapore markets open in 1 hour 6 minutes

  • Straits Times Index

    3,213.65
    -26.93 (-0.83%)
     

  • S&P 500

    3,973.75
    +72.39 (+1.86%)
     

  • Dow

    31,880.24
    +618.34 (+1.98%)
     

  • Nasdaq

    11,535.27
    +180.66 (+1.59%)
     

  • BTC-USD

    29,128.04
    -1,207.47 (-3.98%)
     

  • CMC Crypto 200

    658.56
    -16.31 (-2.42%)
     

  • FTSE 100

    7,513.44
    +123.46 (+1.67%)
     

  • Gold

    1,852.20
    +4.40 (+0.24%)
     

  • Crude Oil

    109.54
    -0.75 (-0.68%)
     

  • 10-Yr Bond

    2.8590
    +0.0720 (+2.58%)
     

  • Nikkei

    27,001.52
    +262.49 (+0.98%)
     

  • Hang Seng

    20,470.06
    -247.18 (-1.19%)
     

  • FTSE Bursa Malaysia

    1,542.53
    -6.59 (-0.43%)
     

  • Jakarta Composite Index

    6,840.77
    -77.37 (-1.12%)
     

  • PSE Index

    6,687.85
    -58.48 (-0.87%)
     
DEALS:

MatchMove Pay buys Singapore startup Shopmatic for US$200 million

Global Real-World Evidence (RWE) Solutions Markets, 2021-2028 - Focus on Market Access, Oncology, Neurology, Post Market Surveillance in Pharma Companies & Providers - ResearchAndMarkets.com

·4-min read

DUBLIN, January 11, 2022--(BUSINESS WIRE)--The "Real-World Evidence (RWE) Solutions Market by Component (Datasets [Clinical, Claims, Pharmacy, Integrated], Services), Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers) - Global Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

The RWE solutions market is expected to grow at a CAGR of 11.8% from 2021 to 2028 to reach $4.4 billion by 2028

Rapidly growing big data in healthcare, shift from volume to value-based care, and rising focus towards personalized healthcare are the key factors driving the growth of the global RWE solutions market. Further, significant growth opportunities for existing market players and new entrants are provided by emerging markets, rising focus on end-to-end RWE services, and the rising adoption of wearable devices and AI in RWE.

Based on component, the datasets segment is expected to command the largest share of the global RWE solutions market due to factors such as the rising dependence of outcome-based studies on real-world data, increasing need for additional insights on epidemiology, compliance, adherence, and costs in a realistic environment, the growing amount of medical data generated in hospitals, and the rising demand for information regarding drug safety among payers, regulatory bodies, and providers.

Based on application, the drug development & approvals segment is expected to witness the fastest growth rate during the forecast period. The increasing investments by pharma and biopharma companies in R&D, increasing demand for real-world data and real-world evidence for accelerating drug discovery and development, and the growing inclination of regulatory bodies towards the use of real-world evidence (RWE) are the factors contributing to the growth of this segment.

Based on end user, the pharmaceutical, biotechnology, & medical device companies segment is expected to witness the fastest growth rate during the forecast period. The increasing importance of RWE studies in drug development &approvals and the growing need to avoid costly drug recalls and assess drug performance in real-world settings are the factors contributing to the growth of this segment.

An in-depth analysis of the geographical scenario of the RWE solutions market provides detailed qualitative and quantitative insights about the five major geographies (North America, Asia-Pacific, Europe, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America is expected to command the largest share of the global RWE solutions market in 2021, followed by Asia-Pacific and Europe.

Market Insights

Drivers

  • Growing Burden of Chronic Diseases

  • Rising Focus Towards Personalized Healthcare

  • Delays in Drug Development and the Subsequent Increase in Development Costs

  • Shift Towards Value-Based Care

  • Rapidly Growing Big Data in Healthcare

Restraints

  • Reluctance to Rely on Real-World Studies

Opportunities

  • Emerging Economies

  • Rising Focus on End-To-End RWE Services

  • Rising Adoption of Wearable Devices and Artificial Intelligence in RWE

Challenges

  • Lack of Standardized Methodologies to Develop RWE

  • Impact Assessment of COVID-19

Key Market Trends

  • Growing Adoption of RWE in Drug Development and Commercialization

  • Rising Number of Consolidations

  • Improved Patient Outcomes and value Creation from real world Evidence

Pricing Models (Emr/Genomic/Integrated Datasets)

  • Pay Per Patient Record (Volume-Based Pricing)

  • Pay Per Usage (Value-Based Pricing)

  • Annual Subscription

The key companies operating in the global RWE solutions market are

  • IQVIA Holdings Inc.

  • ICON plc

  • PPD Inc.

  • SYNEOS HEALTH Inc.

  • CLARIVATE PLC

  • Medpace Holdings Inc.

  • Symphony Innovation LLC

  • Clinigen Group plc

  • Cognizant Technology Solutions Corporation

  • IBM Corporation

  • Oracle Corporation

  • PAREXEL International Corporation

  • PerkinElmer Inc.

  • SAS Institute Inc.

  • UnitedHealth Group Incorporated

  • Flatiron Health

Scope of the Report

Global RWE Solutions Market, by Component

  • Datasets

  • Disparate Datasets

  • EMR/EHR/Clinical Data

  • Claims & Billing Data

  • Pharmacy Data

  • Product/Disease Registries Data

  • Other Disparate Datasets

  • Integrated Datasets

  • Consulting & Analytics

(Note: Other Disparate Datasets include data generated from mobile devices, wearable devices, and social media)

Global RWE Solutions Market, by Application

  • Market Access & Reimbursement/Coverage Decisions

  • Drug Development & Approvals

  • Oncology

  • Neurology

  • Immunology

  • Cardiovascular Diseases

  • Other Therapeutic Areas

  • Post Market Surveillance

  • Medical Device Development & Approvals

  • Other Applications

(Note: Other Therapeutic Areas include infectious diseases, musculoskeletal disorders, dermatological diseases, and respiratory diseases, Other Applications include regulatory and clinical decision-making)

Global RWE Solutions Market, by End User

  • Pharmaceutical, Biotechnology, and Medical Device Companies

  • Healthcare Payers

  • Healthcare Providers

  • Other End Users

(Note: Other end users include academic research institutions, patient advocacy groups, regulators, and health technology assessment agencies)

Global RWE Solutions Market, by Geography

  • North America

  • U.S.

  • Canada

  • Europe

  • Germany

  • France

  • U.K.

  • Italy

  • Spain

  • Rest of Europe (RoE)

  • Asia-Pacific (APAC)

  • Japan

  • China

  • India

  • South Korea

  • Taiwan

  • Singapore

  • Rest of APAC (RoAPAC)

  • Latin America

  • Middle East & Africa

For more information about this report visit https://www.researchandmarkets.com/r/nqlzkw

View source version on businesswire.com: https://www.businesswire.com/news/home/20220111005862/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting

Latest stories

  • MatchMove buys Singapore startup Shopmatic for US$200 million

    Singapore-headquartered fintech MatchMove Pay has acquired fellow e-commerce startup Shopmatic for US$200 million.

  • Indian govt likely to stick to fiscal deficit target, says RBI chief

    MUMBAI (Reuters) -The Indian government is likely to stick to its fiscal deficit target as specified in the budget and there may not necessarily be a need for increasing government borrowing just yet, governor Shaktikanta Das told CNBC-TV18 in an interview on Monday. Experts said the moves will likely increase fiscal concerns and raise doubts about the government meeting its deficit target of 6.4% of GDP for 2022-23.

  • Worried About a Coming Recession? 3 Things You Can Do to Prepare Yourself

    Prime Minister Lee Hsien Loong has warned of a recession that may occur soon. Here's how you can protect your investment portfolio. The post Worried About a Coming Recession? 3 Things You Can Do to Prepare Yourself appeared first on The Smart Investor.

  • Manufacturers getting to grips with airless tyres

    Airless tyres that never go flat or need to be inflated: It's a decades-long dream that manufacturers hope to turn into a reality soon, but for truck drivers first.

  • What Australia's next prime minister says about China, climate change and inflation

    Albanese is seeking improved ties with Pacific nations and Southeast Asia’s largest economy

  • Exclusive-India considering spending additional $26 billion to fight inflation -sources

    The Indian government is considering spending an additional 2 trillion rupees ($26 billion) in the 2022/23 fiscal year to cushion consumers from rising prices and fight multi-year high inflation, two government officials told Reuters. The new measures will be double the 1 trillion rupees hit government revenues could take from tax cuts on petrol and diesel the finance minister announced on Saturday, both the officials said. India’s retail inflation rose to an eight-year high in April, while wholesale inflation rose to at least a 17-year high, posing a major headache for Prime Minister Narendra Modi's government ahead of elections to several state assemblies this year.

  • Didi shareholders vote to delist from New York stock exchange

    Shareholders of Chinese ride-hailing giant Didi Global voted Monday to delist the company in New York, the firm said in a statement, nearly one year since it was hit by a sweeping tech clampdown.

  • MoneyOwl Robo Advisor Review — Is it Better Than Endowus, StashAway & Syfe?

    It sounds a little scary, but MoneyOwl brands itself as “Singapore’s First Bionic Financial Advisor”. No, that doesn’t mean you’ll be served by cyborgs. It does mean, however, that you’ll... The post MoneyOwl Robo Advisor Review — Is it Better Than Endowus, StashAway & Syfe? appeared first on MoneySmart.sg.

  • Yongmao Holdings issues profit warning for 2HFY2022 ended March 31

    The company is expected to report its FY2022 before May 30 2022

  • India's top crypto app CoinSwitch calls for regulatory 'peace, certainty'

    India must establish rules on cryptocurrencies to resolve regulatory uncertainty, protect investors and boost its crypto sector, CoinSwitch CEO Ashish Singhal said on Sunday. Although India's central bank has backed a ban on cryptocurrencies over risks to financial stability, a federal government move to tax income from them has been interpreted by the industry as a sign of acceptance by New Delhi. CoinSwitch, which is valued at $1.9 billion, says it is the largest crypto company in India with more than 18 million users.

  • Indian iron ore and steel stocks slump, autos rise after export tax hikes

    Shares in Indian steel and iron ore groups including Tata Steel and JSW Steel slid on Monday at the steepest pace since early 2020 after the government imposed heavy export taxes on the sector, while carmakers rose on lower input costs. India imposed an export tax of 15% on eight steel products late on Saturday at a time steelmakers are looking to make up for tepid local demand by increasing market share in Europe, whose supplies have been hit by Russia's invasion of Ukraine.

  • Paytm payments bank expects central bank curbs to be lifted in three-five months

    India's Paytm Payments Bank, which facilitates transactions on mobile commerce platform Paytm, expects the central bank to allow it to resume taking on new customers in the next few months, a top executive told Reuters. In March, the Reserve Bank of India ordered a comprehensive audit of the company's IT systems, citing "material" supervisory concerns, without elaborating further, and barring it from taking on new customers. "The process is underway and we think it should take three to five months from where we are right now," Madhur Deora, group chief financial officer, Paytm, told Reuters on Sunday.

  • Integrated Shield Plans (IP) in Singapore: What Are They?

    Hospitalisation coverage is a must-have tool to have in your life due to the ever-rising healthcare costs in the country. According to the...

  • Aspen (Group)'s glove subsidiary receives claim for RM29.35 mil

    Aspen Glove had earlier received a claim of RM84.4 mil from Tialoc Malaysia

  • U.S., Japan, Australia, and India to launch tracking system to monitor illegal fishing by China- FT

    The said that the maritime initiative will use satellite technology to create a tracking system for illegal fishing from the Indian Ocean to the South Pacific by connecting surveillance centers in Singapore and India. U.S. President Joe Biden is visiting Japan to attend the meeting of the Quad group of countries - Australia, India, Japan and the United States in Tokyo- which have increased cooperation in the face of China's growing assertiveness.

  • BingX Launches USDC-Margined Perpetual Swap for its Users

    SINGAPORE - Media OutReach - 23 May 2022 - Social trading platform BingX is pleased to launch its USDC-margined perpetual swap. This new product will allow users to trade using their USDC balance on BingX's derivatives exchange. Using Bitcoin as an example, traders will be able to place an order based on the quantity of bitcoin and trade with USDC. This new perpetual swap joins other existing offerings on BingX's trading platform. "Given the current circumstances, everyone is worried about the v

  • Liv@MB more than 75% sold at average price of $2,387 psf

    The crowd at the preview of Liv@MB a fortnight ago (Credit: Bukit Sembawang Estates)SINGAPORE (EDGEPROP) - Bukit Sembawang Estates announced today that it has sold more than 75% of its 298-unit condo, Liv@MB this weekend. Over 220 units were taken up yesterday (Saturday, May 21), which was its first day of launch, with an average selling price of $2,387 psf. More than 90% of the buyers were said to be Singaporeans residing in the immediate neighbourhood.See also: Conservation bungalow at Mountba

  • Live engagement and voting expected at all AGMs for FYs ending 30 June 2022 or after

    AGMs can still be held virtually, but shareholders should be able to directly and immediately engage with the Boards and vote

  • Changi's Terminal 2 to be re-opened in stages in tandem with air travel recovery

    Passenger traffic has reached more than 40% of pre-Covid levels

  • After meltdown, tech-bottom signals have yet to scream 'buy now'

    "It’s hard to be patient when there's been so much carnage. But the pain should end, possibly soon."